These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6821084)

  • 1. The effect of rifampicin on meningococcal carriage in family contacts in northern Nigeria.
    Blakebrough IS; Gilles HM
    J Infect; 1980 Jun; 2(2):137-43. PubMed ID: 6821084
    [No Abstract]   [Full Text] [Related]  

  • 2. Meningococcal meningitis following rifampin prophylaxis.
    Khuri-Bulos N
    Am J Dis Child; 1973 Nov; 126(5):689-91. PubMed ID: 4200808
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative efficacy of ceftriaxone and rifampicin in eradicating pharyngeal carriage of group A Neisseria meningitidis.
    Schwartz B; Al-Tobaiqi A; Al-Ruwais A; Fontaine RE; A'ashi J; Hightower AW; Broome CV; Music SI
    Lancet; 1988 Jun; 1(8597):1239-42. PubMed ID: 2897515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The carrier state: Neisseria meningitidis.
    Broome CV
    J Antimicrob Chemother; 1986 Jul; 18 Suppl A():25-34. PubMed ID: 3091563
    [No Abstract]   [Full Text] [Related]  

  • 5. Effectiveness of rifampin in eradicating the meningococcal carrier state in a relatively closed population: emergence of resistant strains.
    Weidmer CE; Dunkel TB; Pettyjohn FS; Smith CD; Leibovitz A
    J Infect Dis; 1971 Aug; 124(2):172-8. PubMed ID: 5001453
    [No Abstract]   [Full Text] [Related]  

  • 6. [The use of rifampicin in healthy carriers of "N. meningitidis" (author's transl)].
    Delia S; Mauro A; Miceli MT
    Ann Sclavo; 1978; 20(5):675-80. PubMed ID: 111629
    [No Abstract]   [Full Text] [Related]  

  • 7. [Failure of chemoprophylaxis due to resistance of Neisseria meningitidis to rifampicin].
    Bordessoule A; Hoppé A; Ringuier B; Giniès JL
    Arch Pediatr; 2007 Jan; 14(1):99-100. PubMed ID: 17145173
    [No Abstract]   [Full Text] [Related]  

  • 8. [Alternating rifampicin and ceftriaxone for Neisseria meningitidis eradication in contacts].
    Shehab S; Leitner L; Bogokowsky B; Epstein I; Swartz TA
    Harefuah; 1991 Jun; 120(11):641-3. PubMed ID: 1937208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of sulfadiazine in reducing the nasopharyngeal carriage of Neisseria meningitidis in healthy children.
    Ichhpujani RL; Mohan R; Kumari S; Gupta R; Sehgal PN
    J Commun Dis; 1987 Jun; 19(2):146-51. PubMed ID: 3136201
    [No Abstract]   [Full Text] [Related]  

  • 10. Eradication of carriage of Neisseria meningitidis in families: a study in Brazil.
    Munford RS; Sussuarana de Vasconcelos ZJ; Phillips CJ; Gelli DS; Gorman GW; Risi JB; Feldman RA
    J Infect Dis; 1974 Jun; 129(6):644-9. PubMed ID: 4209720
    [No Abstract]   [Full Text] [Related]  

  • 11. [Efficacy of rifampicin in the treatment of Meningococcus carriers].
    Borgoño JM; Rodríguez H; García J; Cánepa I
    Rev Chil Pediatr; 1981; 52(2):146-8. PubMed ID: 6792661
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effects of rifampin on the carrier state of Neisseria meningitidis and drug-sensitivity test (author's transl)].
    Zhonghua Yu Fang Yi Xue Za Zhi; 1981 Nov; 15(6):371-2. PubMed ID: 6806022
    [No Abstract]   [Full Text] [Related]  

  • 13. Rifampicin-resistant meningococci causing invasive disease and failure of chemoprophylaxis.
    Yagupsky P; Ashkenazi S; Block C
    Lancet; 1993 May; 341(8853):1152-3. PubMed ID: 8097834
    [No Abstract]   [Full Text] [Related]  

  • 14. Prophylaxis for meningococcal disease.
    Artenstein MS
    JAMA; 1975 Mar; 231(10):1035-7. PubMed ID: 803581
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluation of the effect of Rifampin on the nasopharyngeal carriage of Neisseria meningitidis. A preliminary report.
    Beam WE; Newberg NR; Devine LF
    Int Z Klin Pharmakol Ther Toxikol; 1971 Apr; 4(3):316-20. PubMed ID: 4996195
    [No Abstract]   [Full Text] [Related]  

  • 16. Meningococcal meningitis.
    Sohal AS; Rao VR
    Br Med J (Clin Res Ed); 1988 May; 296(6634):1471-2. PubMed ID: 3132305
    [No Abstract]   [Full Text] [Related]  

  • 17. Eradication of nasopharyngeal carriage of Neisseria meningitidis in children and adults in rural Africa: a comparison of ciprofloxacin and rifampicin.
    Cuevas LE; Kazembe P; Mughogho GK; Tillotson GS; Hart CA
    J Infect Dis; 1995 Mar; 171(3):728-31. PubMed ID: 7876629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rifampin-resistant meningococcal disease in a contact patient given prophylactic rifampin.
    Cooper ER; Ellison RT; Smith GS; Blaser MJ; Reller LB; Paisley JW
    J Pediatr; 1986 Jan; 108(1):93-6. PubMed ID: 3080574
    [No Abstract]   [Full Text] [Related]  

  • 19. Trial of a serogroup A meningococcus polysaccharide vaccine in Nigeria.
    Sanborn WR; Bencić Z; Cvjetanović B; Gotschlich EC; Pollock TM; Sippel JE
    Prog Immunobiol Stand; 1971; 5():497-505. PubMed ID: 4633977
    [No Abstract]   [Full Text] [Related]  

  • 20. [Chemoprevention in meningococcal meningitis. A health problem or a social response?].
    Garrido Morales P; Domínguez García A; Pumarola Busquets F
    Med Clin (Barc); 1985 Oct; 85(10):418-22. PubMed ID: 3935888
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.